The SARS-CoV-2 virus has evolved, leading to genetic variation in the community of spreading viral strains, also known as lineages. This genetic diversity can affect a virus’s characteristics, such as its spreading capacity or the severity of its symptoms in infected individuals. This is the reason why health authorities are advocating for Covid Testing San Antonio if people are suspecting any relevant symptoms lately.
Genetic Variations
A change in the genomic sequence of the SARS-CoV-2 virus is referred to as a mutation (also known as a viral mutation or genetic mutation). As the virus circulates expands, it develops mutations that are used to name novel virus sequences. It allows researchers, healthcare professionals, public health officials to have a common term to describe genetic sequence mutations.
PANGO lineage is used to identify name the genetic sequences of SARS-CoV-2. BA.2 BA.2.12.1 are two examples of PANGO lineage names. The Greek alphabet is used the World Health Organization (WHO) to give names to critical SARS-CoV-2 variants, such as delta omicron. A single WHO-named genotype may include several related PANGO lineages. The BA.1.1, BA.2, BA.3, BA.4, BA.5 lineages, for instance, are all part of the omicron variant.
Characteristics
SARS-CoV-2 variants can have a wide range of characteristics. When compared to previous present viruses, some may spread more quickly, show symptoms of resistance to treatment options,/or have no effect. Because of this, public health officials have classified some SARS-CoV-2 mutations as Variants Being Monitored, Variants of Concern, Variants of Interest. Covid Testing San Antonio follows this classification to process the test results.
Impact on Test Performance
Test reports could be affected if a patient sample contains SARS-CoV-2 viruses with mutations. Because each test has a unique design, viral mutations affect them differently in Molecular, Antigen, Serology tests. A test’s design, the sequence of the variant, the prevalence of the subtype in the population are some variables that can influence how mutations alter a test’s performance.
The FDA has coordinated efforts to evaluate the effects of new virus types on tests that have received Emergency Use Authorization. FDA has further routinely monitored publicly available databases worked with stakeholders to understand better the public health implications of new SARS-CoV-2 types their effects on test performance.
Guidelines for Testing
Viral genome mutations can affect viral proteins, affecting how well an antigen or serology test performs. The FDA advises clinical laboratory professionals care providers who perform Covid Testing San Antonio to consider the following:
- False-negative test results can happen due to the SARS-CoV-2 gene’s constant mutations.
- Consider negative findings in light of clinical findings, patient records, epidemiological data.
- If COVID-19 is still suspected after a negative test result, consider repeat testing using another FDA-approved or EUA-authorized molecular diagnostic test (with different genetic targets).
- Some variants might affect test performance.
- Single-target tests are more prone to changes in performance caused viral mutations, which means they are more likely to overlook novel variants.
- Despite the emergence of new variants, tests with multiple outcomes are more likely to carry on as expected.
Conclusion
In addition to these basic recommendations, the FDA is offering details on genotyping tests that are approved for the differentiation identification of particular SARS-CoV-2 mutations lineages, information on particular variants, recommendations for how to use detailed diagnostics that can be impacted genetic variation.
